http://www.fundacionbancosabadell.com/ca/ Banc Sabadell Foundation and the Vall d'Hebron Research Institute (VHIR) have signed an agreement that will finance, with the support of the bank foundation, the tuition of four students in the scholarship program of the 3rd edition of the http://master.vhir.org/ Master in Translational Biomedical Research VHIR. This contribution is the largest made by any entity so far in the Scholarship Program in the two years of the Master.Miquel Molins, President of the Banco Sabadell Foundation, and Dr. Joan Comella, from VHIR, today signed the collaboration agreement between the two organizations at the premises of the Institute, and later have come to some of the laboratories that will host those who receive the grants."We are happy to collaborate with the Master in Translational Biomedical Research of VHIR and to support the training of young researchers in biomedicine," said Miquel Molins. For his part, Dr. Comella said that "thanks to the collaboration of the Banco Sabadell Foundation, the VHIR will train some of the best students with excellent academic records, to continue their research at our institute."The VHIR's Master have already host more than eighty students (37 in the first year and 48 in the second). Most of them, 65, did or are doing internships at the Institute, and currently 12 of these students of the first edition are working as researchers in one of about 60 research groups of VHIR.The Master, affiliated to the Autonomous University of Barcelona (UAB), is focused on the research career, gives access to a PhD program and offers students the opportunity to choose the area of biomedicine in which they want to specialize and develop their education. The most distinctive feature of this Master is that it is taught entirely in a Health Research Institute of tertiary level, by basic researchers, clinicians and doctors who are in constant contact with hospital patients.The location of VHIR within Vall d'Hebron Barcelona Hospital Campus gives the perfect environment to conduct translational biomedical research, always with the patient as the first and last goal.